The U.S. and Europe ambulatory surgery centers market size was valued at USD 58.1 billion in 2019 and expanding at a CAGR of 6% over forecast period 2020 to 2027.
Increasing demand for minimally invasive surgeries (MIS), technological developments in surgical devices and equipment, and surgeons’ control over the choice of such equipment are some of the factors responsible for the market growth. Other factors such as an increase in the incidence of chronic diseases and a rise in geriatric population and thus rising requirement of cost-effective and efficient treatments also contribute to the growth. Rising healthcare costs is anticipated to play a vital role in increasing focus on ambulatory surgery centers (ASCs). These centers allow healthcare professionals to make healthcare services more affordable without having to compromise on the quality of care. This factor is expected to bode well for the market growth in the forthcoming years.
The Medicare-certified ambulatory surgery centers with registered doctors, nurses, and physical therapists at Medicare-certified offer surgical treatment at a low cost. Demand for ASCs is gaining traction for minimally invasive surgical procedures in several fields, including neurosurgery, otorhinolaryngology, and cosmetic surgery. The number of inpatient admissions has significantly decreased in the past years, due to the trend shifting toward ASCs.
In the U.S., more than 65% of total surgeries are performed in ambulatory surgery centers. This is primarily due to high inpatient hospitalization costs and a rise in the adoption of advanced technologies by the ASCs, enabling the provision of rapid and cost-effective treatment.
The use of robotic surgical systems for performing complex surgical procedures and the integration of advanced visualization systems at ASCs are the major factors driving the growth of the market. Rising numbers of mergers and acquisitions are projected to create growth opportunities for the key players operating in the market.
The orthopedics segment held the largest market share of over 24% in 2019. This dominance of the segment is attributed to the large surgical case volume being handled on an outpatient basis and the addition of new procedures under ASC coverage.
More than 60% of the total orthopedic procedures are performed in the multispecialty ASCs in the U.S. With the addition of more complex procedures like total hip replacement under ASC coverage by CMS, the demand for orthopedic surgery in ambulatory surgery centers setting is expected to increase in the forthcoming years. The otolaryngology or ENT segment is expected to witness the highest CAGR during the forecast period followed by a gastroenterology segment.
In Europe, plastic surgery is expected to witness the highest CAGR during the forecast period. The number of plastic surgeries being performed each year is witnessing a rapid rise in the region, owing to the rising trend of body shaping and increasing number of cosmetic and aesthetic procedures. According to The International Association for Ambulatory Surgery (IAAS), Germany, Italy, Greece, Netherlands, and Spain perform the maximum number of plastic surgeries in a year, with around 40% procedures performed in ASCs.
The physician-owned segment held the major market share of around 49% in 2019, which can be attributed to growing physicians’ interests towards standalone ambulatory surgery centers for increased profitability.
In Europe, the majority of day surgery/ ambulatory centers are owned by hospitals and patients can be directly referred to the parent hospital for inpatient admissions. Hospitals are the main facilities providing health care services and have a significant share in terms of healthcare spending. In countries like England, Germany, and France, ambulatory surgery centers are mainly owned by physicians.
The U.S. dominated the market with a revenue share of over 55% in 2019. Presence of sophisticated healthcare facilities, availability of highly advanced equipment and skilled neuro as well as bariatric surgeons, increase in the number of ASCs, rise in the preference for outpatient settings for MIS procedures, and supportive reimbursement framework for medical treatments are among the factors driving the growth of the market in the region.
The Europe ambulatory surgery centers market is anticipated to grow significantly over the forecast period. High incidence of ophthalmic disorders and rising number of cosmetic surgical procedures in day surgery/ ambulatory centers are among the major factors driving the market in the region. In addition, favorable government policies to improve the healthcare system and rapid economic development in many countries are some of the factors anticipated to boost the market over the forecast period.
Some of the prominent players in the U.S. ambulatory surgery centers market include:
Envision Healthcare Corporation
Tenet Healthcare Corporation
MEDNAX Services, Inc.
Quorum Health Corporation
Surgical Care Affiliates (SCA)
Community Health Systems, Inc.
HCA Healthcare, Inc.
Surgical Center Development, Inc.
Some of the prominent players in the Europe ambulatory surgery centers market include:
Chelsea & Westminster Hospital
Zudecche Day Surgery
The Alan Cumming Day Surgery Unit
London Day Surgery Centre
Ghent University Hospital
Pain Management/Spinal Injections